<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kevin R Krull, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eugenia Chan, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marilyn Augustyn, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 09, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Attention deficit hyperactivity disorder (ADHD) is a disorder that manifests in childhood with symptoms of hyperactivity, impulsivity, and/or inattention. The symptoms affect cognitive, academic, behavioral, emotional, and social functioning [<a href="#rid1">1</a>].</p><p>This topic review focuses on the epidemiology and pathogenesis of ADHD. The evaluation, diagnosis, management, and prognosis of ADHD in children and ADHD in adults are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/623.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/621.html" rel="external">"Pharmacology of drugs used to treat attention deficit hyperactivity disorder in children and adolescents"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1232.html" rel="external">"Attention deficit hyperactivity disorder in adults: Epidemiology, clinical features, assessment, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">DEFINITION</span><span class="headingEndMark"> — </span>ADHD is a disorder that manifests in early childhood with symptoms of hyperactivity, impulsivity, and/or inattention. The symptoms affect cognitive, academic, behavioral, emotional, and social functioning [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis", section on 'Core symptoms'</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H4"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>The reported prevalence of ADHD in children varies from 2 to 18 percent depending upon the diagnostic criteria and the population studied (eg, primary care versus referral) [<a href="#rid1">1-5</a>]. The prevalence in school-age children is estimated to be between 9 and 15 percent, making it one of the most common disorders of childhood [<a href="#rid3">3,5-10</a>]. In a meta-analysis of 175 studies (including 1,023,071 subjects over 36 years), the estimated pooled prevalence of ADHD was 7.2 percent (95% CI 6.7 to 7.8) [<a href="#rid11">11</a>]. The studies were from a broad geographic distribution (eg, Europe, Asia, North America). Most were conducted in school-age children.</p><p>In the 2015 to 2016 National Health Interview Survey (NHIS), the weighted prevalence of a caregiver-reported diagnosis of ADHD among children aged 4 to 17 years of age in the United States was 10 percent [<a href="#rid12">12</a>]. This is an increase from 6 percent in 1997 to 1998. The prevalence increased with increasing age (7.7 percent among 4- to 11-year-olds and 13.5 percent among 12- to 17-year-olds).</p><p>ADHD is more common in males than females (male to female ratio 4:1 for the predominantly hyperactive presentation and 2:1 for the predominantly inattentive presentation) [<a href="#rid13">13</a>]. In the 2015 to 2016 NHIS, the prevalence was 14 percent in males and 6 percent in females [<a href="#rid12">12</a>].</p><p>ADHD is not a reportable disease. The primary sources of information regarding prevalence are parent report and extrapolation from medical records, billing, or pharmacy records – each of which has limitations. Potential explanations for the apparent increase in prevalence of ADHD over time include improved awareness and case-identification by primary care professionals, educators, and parents or more frequent exposure to some of the potential etiologic factors discussed below. (See <a class="local">'Pathogenesis: Potential environmental influences'</a> below.)</p><p class="headingAnchor" id="H5"><span class="h2">Comorbid disorders</span><span class="headingEndMark"> — </span>Children and adolescents with ADHD frequently have comorbid psychiatric and neurodevelopmental disorders, including (but not limited to) oppositional defiant disorder (ODD), conduct disorder, depression, anxiety disorder, autism spectrum disorder (ASD), and learning disorders [<a href="#rid14">14-20</a>]. The comorbid conditions can be primary or secondary (eg, exacerbated by the ADHD). In either case, they require treatment independent of, but often in addition to, the treatment for ADHD [<a href="#rid5">5,21,22</a>]. (See  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis", section on 'Evaluation for coexisting disorders'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Oppositional defiant disorder</strong> – ODD coexists with ADHD in approximately 50 to 80 percent of cases [<a href="#rid13">13,19,23</a>]. It is more common in children with the combined and hyperactive-impulsive presentations [<a href="#rid24">24,25</a>]. Their excessive activity, impulsive response style, and disinhibited emotional expression frequently put them in conflict with caregivers and other adults. The increased conflict may lead to increased discipline and less positive reinforcement for the child. Under these circumstances, a potentially self-perpetuating pattern of oppositional defiant behavior can emerge (the oppositional acts bring parental attention, which is reinforcing for the child who rarely receives parental praise) [<a href="#rid26">26-28</a>]. (See  <a class="medical medical_review" href="/d/html/121430.html" rel="external">"Oppositional defiant disorder: Epidemiology, clinical manifestations, course, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Conduct disorder</strong> – Conduct disorder coexists with ADHD in as many as one-third of cases [<a href="#rid13">13,14,19</a>]. Like ODD, it is more common in the combined and hyperactive-impulsive presentations [<a href="#rid24">24,25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anxiety disorder</strong> – Anxiety disorder coexists with ADHD in approximately 20 to 40 percent of cases [<a href="#rid13">13,14,19,23</a>]. It occurs more frequently in the inattentive presentation [<a href="#rid13">13,24,25</a>]. Anxiety may develop as a secondary disorder in children with ADHD; however, in many cases, anxiety appears to be a distinct disorder and may be independent of ADHD [<a href="#rid15">15,29</a>]. (See  <a class="medical medical_review" href="/d/html/15926.html" rel="external">"Anxiety disorders in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, and course"</a> and  <a class="medical medical_review" href="/d/html/15928.html" rel="external">"Pharmacotherapy for anxiety disorders in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Depression</strong> – Depression coexists with ADHD in as many as one-third of cases [<a href="#rid13">13,14,19,23</a>]. It appears be more common in the inattentive and combined presentations [<a href="#rid24">24,25</a>]. Children with ADHD and comorbid mood disorder may have family members with a history of major depressive disorder [<a href="#rid17">17</a>]. Adolescents with ADHD and mood disorder are at increased risk for attempting suicide [<a href="#rid30">30-32</a>]. (See  <a class="medical medical_review" href="/d/html/1224.html" rel="external">"Pediatric unipolar depression: Epidemiology, clinical features, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/1229.html" rel="external">"Suicidal behavior in children and adolescents: Epidemiology and risk factors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Learning disorder</strong> – Estimates for the coexistence of learning disorders and ADHD range from 20 to 60 percent [<a href="#rid13">13,14,18,26,33</a>]. In a population-based birth cohort, approximately 40 percent of children with ADHD also had reading disability, and approximately 60 percent of children with ADHD also had written-language disorder [<a href="#rid33">33,34</a>]. Learning disorders appear to occur more commonly among children with the inattentive and combined presentations of ADHD [<a href="#rid24">24,25</a>]. (See  <a class="medical medical_review" href="/d/html/610.html" rel="external">"Specific learning disorders in children: Clinical features", section on 'Comorbidities'</a>.)</p><p></p><p class="bulletIndent1">Data regarding the rates of coexistence of specific types of learning disorders and ADHD are lacking. In a study of 445 ninth-grade students, children with reading disabilities were twice as likely to meet diagnostic criteria for the inattentive presentation than the general population (15 versus 7 percent) [<a href="#rid35">35</a>]. Conversely, individuals with ADHD were at higher risk than the general population for reading disability or phonologic awareness deficit (36 versus 17 percent). (See  <a class="medical medical_review" href="/d/html/598.html" rel="external">"Reading difficulty in children: Normal reading development and etiology of reading difficulty"</a> and  <a class="medical medical_review" href="/d/html/600.html" rel="external">"Reading difficulty in children: Clinical features and evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Developmental coordination disorder</strong> – Approximately one-half of children with ADHD meet criteria for developmental coordination disorder (DCD). The association between ADHD and DCD is discussed separately. (See  <a class="medical medical_review" href="/d/html/594.html" rel="external">"Developmental coordination disorder: Clinical features and diagnosis", section on 'Evaluation for associated conditions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Autism spectrum disorder </strong>– ASD often coexists with ADHD, though many children with ADHD do not have ASD [<a href="#rid36">36,37</a>]. In children with comorbid ADHD and ASD, initial diagnosis of ADHD may delay diagnosis of ASD [<a href="#rid38">38</a>]. Children with comorbid ADHD and ASD usually have more severe cognitive impairment, behavior problems, and psychopathology than children with isolated ADHD or ASD [<a href="#rid39">39-42</a>]. (See  <a class="medical medical_review" href="/d/html/627.html" rel="external">"Autism spectrum disorder in children and adolescents: Clinical features"</a> and  <a class="medical medical_review" href="/d/html/628.html" rel="external">"Autism spectrum disorder in children and adolescents: Evaluation and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sleep disorders </strong>– Children with ADHD may have comorbid sleep disorders [<a href="#rid5">5</a>]. In addition, sleep disturbances underlie behavioral symptoms. The association between sleep disturbances and ADHD is discussed separately. (See  <a class="medical medical_review" href="/d/html/6363.html" rel="external">"Evaluation of suspected obstructive sleep apnea in children", section on 'Daytime symptoms'</a> and  <a class="medical medical_review" href="/d/html/16641.html" rel="external">"Cognitive and behavioral consequences of sleep disorders in children", section on 'Clinical consequences of sleep deficiency'</a> and  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis", section on 'Differential diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H6"><span class="h1">PATHOGENESIS: PRIMARY FACTORS</span><span class="headingEndMark"> — </span>The pathogenesis of ADHD is not definitively known. A genetic imbalance of catecholamine metabolism in the cerebral cortex appears to play a primary role, as illustrated by structural and functional brain imaging, animal studies, and the response to drugs with noradrenergic activity (eg, <a class="drug drug_pediatric" data-topicid="12600" href="/d/drug information/12600.html" rel="external">methylphenidate</a>) [<a href="#rid23">23,43,44</a>]. However, various environmental factors may play a secondary role; the significance of environmental factors is controversial. (See <a class="local">'Pathogenesis: Potential environmental influences'</a> below.)</p><p class="headingAnchor" id="H7"><span class="h2">Genetic factors</span><span class="headingEndMark"> — </span>A genetic contribution to the pathogenesis of ADHD is supported by the increased risk of ADHD in first-degree relatives of patients with ADHD and twin studies from different countries that consistently provide heritability estimates of approximately 75 percent [<a href="#rid45">45-48</a>]. Although genetic variants associated with ADHD have been identified (eg, single nucleotide polymorphisms, copy number variants), the identified genetic variants are not specific for ADHD [<a href="#rid46">46,49</a>]. (See  <a class="medical medical_review" href="/d/html/16647.html" rel="external">"Genomic disorders: An overview", section on 'Copy number variations'</a> and  <a class="medical medical_review" href="/d/html/2900.html" rel="external">"Basic genetics concepts: DNA regulation and gene expression", section on 'Genetic variation'</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Neuroanatomy</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Structural and functional differences</strong> – Structural brain imaging in groups of children with and without ADHD demonstrates significant differences in many areas [<a href="#rid50">50</a>]. In observational studies, children with ADHD have reversed or absent asymmetry of the caudate nucleus, smaller cerebral and cerebellar volume, smaller posterior corpus callosum regions, and increased gray matter in the posterior temporal and inferior parietal cortices compared with children without ADHD [<a href="#rid51">51-54</a>]. Differences are particularly noted in anterior brain areas, including smaller prefrontal cortical volumes and reduced thickness of the anterior cingulate cortex, as well as cortical thinning in bilateral superior frontal brain regions [<a href="#rid55">55-58</a>].</p><p></p><p class="bulletIndent1">Functional brain imaging reveals that groups of children with ADHD have reduced global activation and reduced local activation in the areas of the basal ganglia and anterior frontal lobe [<a href="#rid59">59-65</a>]. The administration of <a class="drug drug_pediatric" data-topicid="12600" href="/d/drug information/12600.html" rel="external">methylphenidate</a> affects activation in these and other areas. However, the effect varies depending upon the area, with age, and whether the child has ADHD [<a href="#rid66">66,67</a>]. These findings support the hypothesis that ADHD is characterized by atypical frontal-striatal function and that methylphenidate affects striatal activation differently in ADHD than in healthy children.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical correlation</strong> – Neuropsychologic testing suggests that patients with ADHD have impaired executive functions (processes involved in forward planning, including abstract reasoning, mental flexibility, working memory) and/or difficulties with response inhibition [<a href="#rid68">68,69</a>]. These findings are consistent with neuroimaging studies that demonstrate structural and functional abnormalities in prefrontal structures and basal ganglia regions (which underlie motor response inhibition and executive functions) [<a href="#rid70">70-72</a>].</p><p></p><p class="headingAnchor" id="H10"><span class="h2">Catecholamine metabolism</span><span class="headingEndMark"> — </span>Catecholamines include dopamine and epinephrine. Catecholamine metabolism appears to play a role in ADHD pathogenesis [<a href="#rid46">46,73</a>]. In animal studies, the noradrenergic system is involved in the modulation of higher cortical functions, including attention, alertness, vigilance, and executive function [<a href="#rid74">74</a>]. Rat models suggest that an imbalance between the norepinephrine and dopamine systems in the prefrontal cortex contributes to the pathogenesis of ADHD (decrease in inhibitory dopaminergic activity and increase in norepinephrine activity) [<a href="#rid75">75</a>].</p><p>The findings from animal studies are supported by human studies indicating patients with ADHD have an increase in dopamine transporter density (which may clear dopamine from the synapse too quickly) compared with healthy controls [<a href="#rid76">76</a>] and that <a class="drug drug_pediatric" data-topicid="12600" href="/d/drug information/12600.html" rel="external">methylphenidate</a> increases extracellular dopamine in the brain [<a href="#rid77">77</a>].</p><p class="headingAnchor" id="H11"><span class="h1">PATHOGENESIS: POTENTIAL ENVIRONMENTAL INFLUENCES</span><span class="headingEndMark"> — </span>Various environmental factors may play a secondary role in the pathogenesis of ADHD [<a href="#rid43">43,44,78</a>]. The significance of environmental factors is controversial.</p><p>When considering the contribution of environmental factors, it is important to distinguish between the behavioral symptoms of ADHD and the clinical syndrome of ADHD. Inattentiveness, impulsivity, and hyperactivity occur to some extent in all children. It is the persistence, pervasiveness, developmental inappropriateness, and functional complications of the behavioral symptoms that lead to a diagnosis of ADHD. To meet criteria for ADHD, symptoms must [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Be present in more than one setting (eg, school and home)</p><p class="bulletIndent1"><span class="glyph">●</span>Persist for at least six months</p><p class="bulletIndent1"><span class="glyph">●</span>Be present before the age of 12 years</p><p class="bulletIndent1"><span class="glyph">●</span>Impair function in academic, social, or occupational activities</p><p class="bulletIndent1"><span class="glyph">●</span>Be excessive for the developmental level of the child</p><p class="bulletIndent1"><span class="glyph">●</span>Not be caused by other mental disorders</p><p></p><p>The clinical features and diagnosis of ADHD are discussed separately. (See  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis", section on 'Diagnostic criteria'</a> and  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis"</a>.)</p><p class="headingAnchor" id="H12"><span class="h2">Dietary influences</span><span class="headingEndMark"> — </span>The influence of diet on attention, hyperactivity, and behavior is controversial. The evidence relating diet to ADHD symptoms is limited; it consists predominantly of observational studies based on caregiver reports.</p><p>Areas of investigation include:</p><p class="bulletIndent1"><span class="glyph">●</span>Food additives (artificial colors, artificial flavors, preservatives)</p><p class="bulletIndent1"><span class="glyph">●</span>Refined sugar intake</p><p class="bulletIndent1"><span class="glyph">●</span>Food sensitivity (allergy or intolerance)</p><p class="bulletIndent1"><span class="glyph">●</span>Various fatty acid deficiencies</p><p class="bulletIndent1"><span class="glyph">●</span>Iron and zinc deficiency</p><p></p><p>These dietary factors generally do not impact behavior to a clinically significant level and do not account for the majority of cases of ADHD [<a href="#rid43">43,79</a>]. However, a small subset of children may demonstrate mild adverse behavior or inattention on diets containing food additives, artificial colors, excess sugar, or reduced intake of essential fatty acids and minerals. Similarly, food sensitivity may be associated with behavioral abnormalities, but only infrequently with the clinical syndrome of ADHD. (See  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis", section on 'Diagnostic criteria'</a>.)</p><p>The implications of these findings on the management of children with ADHD are discussed separately. (See  <a class="medical medical_review" href="/d/html/623.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis", section on 'Dietary interventions'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Food additives</strong> – The effect of food additives (artificial colors and flavors, preservatives) on the behavior of children is an active area of investigation. Although some studies support a relationship between food additives and ADHD symptoms in some children, they do not prove that food additives cause ADHD. Major practice guidelines for the treatment of ADHD and for food allergy management do not routinely recommend elimination of food additives in the management of children with ADHD [<a href="#rid5">5,23,44,80,81</a>]. (See  <a class="medical medical_review" href="/d/html/623.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis", section on 'Elimination diets'</a>.) </p><p></p><p class="bulletIndent1">The body of literature focusing on the behavioral effects of food additives suggests that some children (both with and without ADHD) may have identifiable sensitivity to specific additives [<a href="#rid82">82-87</a>]. However, this conclusion is not universally accepted, and the issue remains controversial. In March 2011, the Food Advisory Committee of the US Food and Drug Administration determined that existing data do not support a causal link between consumption of color additives and hyperactivity or other problematic behaviors in children [<a href="#rid88">88</a>].</p><p></p><p class="bulletIndent1">Food additives were first suggested as a potential cause of hyperactive behavior in the 1970s [<a href="#rid89">89</a>]. Studies that followed yielded mixed results. In a 2012 meta-analysis of five randomized crossover studies, restriction diets reduced ADHD symptoms in children (effect size 0.29, 95% CI 0.16-0.52) [<a href="#rid85">85</a>]. Masked challenge with specific food colors had a small effect on caregiver-reported ADHD symptoms (20 studies, 794 participants, effect size 0.18, 95% CI 0.08-0.29), and a non-significant effect on teacher-reported symptoms (10 studies, 323 participants effect size 0.07, 95% CI -0.03-0.18). This discrepancy between parent and health professional/teacher report of symptoms has been noted in other studies [<a href="#rid82">82,90</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Refined sugar</strong> – Adverse behavior effects, including hyperactivity, are commonly attributed to excess sugar intake by parents and teachers [<a href="#rid91">91,92</a>]. There are two proposed mechanisms: sensitivity to refined sugar and functional reactive hypoglycemia (which triggers release of stress hormones such as adrenaline) after ingesting sugar [<a href="#rid83">83,93</a>].</p><p></p><p class="bulletIndent1">A meta-analysis of 23 studies in which sugar was eliminated from the diet and/or children were challenged with sugar failed to support an association between sugar intake and hyperactivity, attention span, or cognitive functioning [<a href="#rid94">94</a>]. However, a small effect of sugar on subsets of children could not be excluded. A 2005 systematic review that included a slightly different set of trials supported the conclusion of the earlier meta-analysis but points out that most of the trials used relatively low-sugar challenges (equivalent to roughly one 16 ounce bottle of soda) [<a href="#rid83">83</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unhealthy eating patterns</strong> – Unhealthy eating patterns include consumption of food additives, refined sugars, saturated fat, and processed/ultraprocessed foods, combining several independent dietary influences. A meta-analyses of observational studies found weak evidence that unhealthy eating patterns were associated with increased risk of ADHD [<a href="#rid95">95</a>]. In contrast, healthy eating patterns (eg, plant-based with little consumption of food additives, refined sugars, saturated fat, and processed/ultraprocessed foods) were associated with decreased risk of ADHD.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Food sensitivity</strong> – For most children, food sensitivity does not appear to contribute to the pathogenesis of ADHD. There are few well-designed trials evaluating the potential association between food sensitivity (allergy or intolerance) and behavior. Demonstration of such an association requires removal of the suspect food(s) from the child's diet (elimination diet) followed by challenge with the suspect food(s) versus placebo [<a href="#rid83">83</a>].</p><p></p><p class="bulletIndent1">The oligoallergenic diet (OAD) is an example of an elimination diet that may be used to assess the relationship between food sensitivity and behavior. The OAD restricts intake to a few foods that are unlikely to cause allergy (eg, turkey, lamb, rice, potato, banana, apple, pear, a few vegetables, water, salt and pepper) [<a href="#rid83">83</a>]. Although parents and teachers must supervise the elimination diet, which precludes blinding during this stage, they can be blinded when the child is challenged with the suspect food(s).</p><p></p><p class="bulletIndent1">A review of double-blind placebo-controlled trials of the OAD in children with ADHD [<a href="#rid96">96-99</a>] found that behavior improved during the elimination phase [<a href="#rid83">83</a>]. However, behavior also improved during the placebo phases of the food challenge [<a href="#rid96">96-98</a>], or when the OAD diet was compared with a placebo diet (common foods with similar appearance to foods included in the OAD) [<a href="#rid99">99</a>]. The authors of the review concluded that some children may have identifiable sensitivities to certain foods. Nonetheless, food sensitivity plays no role in the majority of cases of ADHD.</p><p></p><p class="bulletIndent1">A subsequent randomized trial determined that the identification of foods that may be associated with ADHD symptoms cannot be achieved by measuring immunoglobulin G levels, a common practice in complementary medicine [<a href="#rid100">100,101</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fatty acid deficiency</strong> – Long-chain polyunsaturated fatty acids (LCPUFA) include the n-3 (or omega-3) fatty acids (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) and the n-6 (or omega-6) fatty acid, arachidonic acid. LCPUFA are necessary for the development and functioning of neuronal membranes.</p><p></p><p class="bulletIndent1">Some studies have noted decreased concentrations of various fatty acids (eg, free fatty acids, n-3 LCPUFA) in the serum of children with ADHD and/or lower ratios of n-3 LCPUFA to n-6 LCPUFA, suggesting that deficiency of certain fatty acids may play a role in the pathogenesis of ADHD [<a href="#rid102">102-106</a>]. However, evidence that fatty acid supplementation improves ADHD symptoms is limited, and the role of fatty acid supplementation in the pathogenesis of ADHD remains unclear [<a href="#rid87">87,107-110</a>]. (See  <a class="medical medical_review" href="/d/html/623.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis", section on 'Essential fatty acid supplementation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Iron deficiency</strong> – The role of iron deficiency in ADHD has not been clearly defined. However, low serum ferritin has been associated with cognitive and learning disorders, and iron deficiency has been associated with abnormal dopaminergic neurotransmission (iron is a co-enzyme of dopamine synthesis) [<a href="#rid111">111,112</a>]. In addition, there appears to be an overlap between restless leg syndrome (which is associated with iron deficiency) and ADHD symptoms in children [<a href="#rid113">113,114</a>]. (See  <a class="medical medical_review" href="/d/html/16995.html" rel="external">"Restless legs syndrome and periodic limb movement disorder in children", section on 'Iron deficiency'</a>.)</p><p></p><p class="bulletIndent1">Case-control studies of ferritin levels in children with ADHD have had inconsistent results [<a href="#rid112">112,115-118</a>]. Additional studies are necessary to confirm or refute an association between iron deficiency and ADHD [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Zinc deficiency</strong> – Several controlled studies demonstrating zinc deficiency or a beneficial response to zinc supplementation in children with ADHD suggest that zinc deficiency may play a role in the pathogenesis of ADHD [<a href="#rid119">119,120</a>]. However, a systematic review of three randomized trials did not find a beneficial effect of zinc on ADHD symptoms [<a href="#rid121">121</a>]. Additional studies are necessary to confirm this hypothesis [<a href="#rid43">43,120</a>].</p><p></p><p class="headingAnchor" id="H152104264"><span class="h2">Sleep deficiency</span><span class="headingEndMark"> — </span>Insufficient sleep may exacerbate symptoms of ADHD. Behavioral consequences of sleep deficiency are discussed separately. (See  <a class="medical medical_review" href="/d/html/16641.html" rel="external">"Cognitive and behavioral consequences of sleep disorders in children", section on 'Clinical consequences of sleep deficiency'</a>.)</p><p class="headingAnchor" id="H1028212"><span class="h2">Prenatal medications</span><span class="headingEndMark"> — </span>The unproven associations between ADHD and prenatal exposure to antidepressants and <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> are discussed separately. (See  <a class="medical medical_review" href="/d/html/114320.html" rel="external">"Antenatal exposure to selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs): Risk of psychopathology in the offspring", section on 'Attention deficit hyperactivity disorder'</a> and  <a class="medical medical_review" href="/d/html/112420.html" rel="external">"Prenatal care: Patient education, health promotion, and safety of commonly used drugs", section on 'Acetaminophen'</a>.)</p><p class="headingAnchor" id="H1500690978"><span class="h2">Prenatal exposure to tobacco smoke</span><span class="headingEndMark"> — </span>Prenatal exposure to tobacco smoke is consistently associated with development of ADHD in case-control and cohort studies [<a href="#rid122">122,123</a>]. It is uncertain whether this association is causal or mediated by unmeasured environmental or genetic confounders [<a href="#rid124">124-126</a>]. (See  <a class="medical medical_review" href="/d/html/4803.html" rel="external">"Cigarette and tobacco products in pregnancy: Impact on pregnancy and the neonate", section on 'Long-term effects'</a>.)</p><p class="headingAnchor" id="H7255981"><span class="h2">Prematurity</span><span class="headingEndMark"> — </span>Observational studies and meta-analysis of observational studies also suggest that prematurity and low birth weight are associated with ADHD, although it uncertain whether this association is causal. (See  <a class="medical medical_review" href="/d/html/4967.html" rel="external">"Long-term neurodevelopmental impairment in infants born preterm: Epidemiology and risk factors"</a>.)</p><p class="headingAnchor" id="H19"><span class="h2">Other factors</span><span class="headingEndMark"> — </span>Other factors that have been associated with the development of ADHD, but in which the association is inconsistent, include [<a href="#rid43">43,78</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Prenatal exposure to alcohol [<a href="#rid127">127-131</a>] (see  <a class="medical medical_review" href="/d/html/14381.html" rel="external">"Fetal alcohol spectrum disorder: Clinical features and diagnosis", section on 'Central nervous system involvement'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Head trauma in young children [<a href="#rid132">132</a>] (see  <a class="medical medical_review" href="/d/html/93336.html" rel="external">"Minor head trauma in infants and children: Management", section on 'Complications'</a>)</p><p></p><p class="headingAnchor" id="H3886731951"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/117871.html" rel="external">"Society guideline links: Attention deficit hyperactivity disorder"</a>.)</p><p class="headingAnchor" id="H21274481"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15361.html" rel="external">"Patient education: Attention deficit hyperactivity disorder (ADHD) in children (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/1210.html" rel="external">"Patient education: Symptoms and diagnosis of attention deficit hyperactivity disorder in children (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Attention deficit hyperactivity disorder (ADHD) is a disorder that manifests in early childhood with symptoms of hyperactivity, impulsivity, and/or inattention. (See <a class="local">'Definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence</strong> – The prevalence of ADHD is estimated to be between 8 and 10 percent in school-age children; it is more common in males than females. (See <a class="local">'Prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Comorbid disorders </strong>– Children and adolescents with ADHD frequently have comorbid disorders, including oppositional defiant disorder, conduct disorder, depression, anxiety disorder, learning disorders, developmental coordination disorder, autism spectrum disorder, and sleep disorders. Sleep deficiency may be an exacerbating factor. (See <a class="local">'Comorbid disorders'</a> above and <a class="local">'Sleep deficiency'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis </strong>– The pathogenesis of ADHD is not definitively known. A genetic imbalance of catecholamine metabolism in the cerebral cortex appears to play a primary role. (See <a class="local">'Pathogenesis: Primary factors'</a> above.)</p><p></p><p class="bulletIndent1">Various environmental factors may play a secondary role in the pathogenesis of ADHD; the significance of environmental factors is controversial. (See <a class="local">'Pathogenesis: Potential environmental influences'</a> above.)</p><p></p><p class="bulletIndent1">Dietary factors (food additives, sugar, food sensitivity, essential fatty acid deficiency, mineral deficiency) generally do not impact behavior to a clinically significant level and do not account for the majority of cases of ADHD. However, a small subset of children may demonstrate mild adverse behavioral effects in response to dietary influences. (See <a class="local">'Dietary influences'</a> above.)</p><p></p><p class="bulletIndent1">Prenatal exposure to tobacco and prematurity/low birth weight are associated with development of ADHD. Other factors that have been associated with the development of ADHD, but in which the association is inconsistent, include prenatal exposure to alcohol and head trauma. (See <a class="local">'Other factors'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">American Psychiatric Association. Attention-deficit/hyperactivity disorder. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, American Psychiatric Association, Washington, DC 2022. p.68.</li><li><a class="nounderline abstract_t">Barbaresi W, Katusic S, Colligan R, et al. How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Paediatr Suppl 2004; 93:55.</a></li><li><a class="nounderline abstract_t">Merikangas KR, He JP, Brody D, et al. Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES. Pediatrics 2010; 125:75.</a></li><li><a class="nounderline abstract_t">Danielson ML, Bitsko RH, Ghandour RM, et al. Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016. J Clin Child Adolesc Psychol 2018; 47:199.</a></li><li><a class="nounderline abstract_t">Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Perou R, Bitsko RH, Blumberg SJ, et al. Mental health surveillance among children--United States, 2005-2011. MMWR Suppl 2013; 62:1.</a></li><li><a class="nounderline abstract_t">Visser SN, Danielson ML, Bitsko RH, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry 2014; 53:34.</a></li><li><a class="nounderline abstract_t">Wolraich ML, McKeown RE, Visser SN, et al. The prevalence of ADHD: its diagnosis and treatment in four school districts across two states. J Atten Disord 2014; 18:563.</a></li><li><a class="nounderline abstract_t">Rowland AS, Skipper BJ, Umbach DM, et al. The Prevalence of ADHD in a Population-Based Sample. J Atten Disord 2015; 19:741.</a></li><li><a class="nounderline abstract_t">Zablotsky B, Black LI, Maenner MJ, et al. Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009-2017. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Thomas R, Sanders S, Doust J, et al. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 2015; 135:e994.</a></li><li><a class="nounderline abstract_t">Xu G, Strathearn L, Liu B, et al. Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016. JAMA Netw Open 2018; 1:e181471.</a></li><li class="breakAll">Agency for Healthcare Research and Quality. Diagnosis of Attention-Deficit/Hyperactivity Disorder. Clinical Focus. Rockville, MD, October 1999. www.ahrq.gov/clinic/tp/adhddtp.htm (Accessed on October 25, 2011).</li><li><a class="nounderline abstract_t">Larson K, Russ SA, Kahn RS, Halfon N. Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics 2011; 127:462.</a></li><li><a class="nounderline abstract_t">Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2001; 40:147.</a></li><li><a class="nounderline abstract_t">Levy F, Hay DA, Bennett KS, McStephen M. Gender differences in ADHD subtype comorbidity. J Am Acad Child Adolesc Psychiatry 2005; 44:368.</a></li><li><a class="nounderline abstract_t">Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991; 148:564.</a></li><li><a class="nounderline abstract_t">Koolwijk I, Stein DS, Chan E, et al. "Complex" attention-deficit hyperactivity disorder, more norm than exception? Diagnoses and comorbidities in a developmental clinic. J Dev Behav Pediatr 2014; 35:591.</a></li><li><a class="nounderline abstract_t">Tung I, Li JJ, Meza JI, et al. Patterns of Comorbidity Among Girls With ADHD: A Meta-analysis. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Bélanger SA, Andrews D, Gray C, Korczak D. ADHD in children and youth: Part 1-Etiology, diagnosis, and comorbidity. Paediatr Child Health 2018; 23:447.</a></li><li><a class="nounderline abstract_t">Barbaresi WJ, Campbell L, Diekroger EA, et al. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. J Dev Behav Pediatr 2020; 41 Suppl 2S:S35.</a></li><li><a class="nounderline abstract_t">Barbaresi WJ, Campbell L, Diekroger EA, et al. The Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder: Process of Care Algorithms. J Dev Behav Pediatr 2020; 41 Suppl 2S:S58.</a></li><li><a class="nounderline abstract_t">Pliszka S, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46:894.</a></li><li><a class="nounderline abstract_t">Wolraich ML, Hannah JN, Pinnock TY, et al. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 1996; 35:319.</a></li><li><a class="nounderline abstract_t">Wolraich ML, Hannah JN, Baumgaertel A, Feurer ID. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr 1998; 19:162.</a></li><li><a class="nounderline abstract_t">Pliszka SR. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000; 9:525.</a></li><li><a class="nounderline abstract_t">Lalonde J, Turgay A, Hudson JI. Attention-deficit hyperactivity disorder subtypes and comorbid disruptive behaviour disorders in a child and adolescent mental health clinic. Can J Psychiatry 1998; 43:623.</a></li><li><a class="nounderline abstract_t">Barkley RA, Fischer M, Edelbrock C, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria--III. Mother-child interactions, family conflicts and maternal psychopathology. J Child Psychol Psychiatry 1991; 32:233.</a></li><li><a class="nounderline abstract_t">Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry 1998; 59 Suppl 7:50.</a></li><li><a class="nounderline abstract_t">Lam LT. Attention deficit disorder and hospitalization owing to intra- and interpersonal violence among children and young adolescents. J Adolesc Health 2005; 36:19.</a></li><li><a class="nounderline abstract_t">Brent DA, Perper JA, Goldstein CE, et al. Risk factors for adolescent suicide. A comparison of adolescent suicide victims with suicidal inpatients. Arch Gen Psychiatry 1988; 45:581.</a></li><li><a class="nounderline abstract_t">Nasser EH, Overholser JC. Assessing varying degrees of lethality in depressed adolescent suicide attempters. Acta Psychiatr Scand 1999; 99:423.</a></li><li><a class="nounderline abstract_t">Yoshimasu K, Barbaresi WJ, Colligan RC, et al. Gender, attention-deficit/hyperactivity disorder, and reading disability in a population-based birth cohort. Pediatrics 2010; 126:e788.</a></li><li><a class="nounderline abstract_t">Yoshimasu K, Barbaresi WJ, Colligan RC, et al. Written-language disorder among children with and without ADHD in a population-based birth cohort. Pediatrics 2011; 128:e605.</a></li><li><a class="nounderline abstract_t">Shaywitz SE, Fletcher JM, Shaywitz BA. Issues in the definition and classification of attention deficit disorder. Top Lang Disord 1994; 14:1.</a></li><li><a class="nounderline abstract_t">Brookman-Frazee L, Stadnick N, Chlebowski C, et al. Characterizing psychiatric comorbidity in children with autism spectrum disorder receiving publicly funded mental health services. Autism 2018; 22:938.</a></li><li><a class="nounderline abstract_t">Hollingdale J, Woodhouse E, Young S, et al. Autistic spectrum disorder symptoms in children and adolescents with attention-deficit/hyperactivity disorder: a meta-analytical review. Psychol Med 2020; 50:2240.</a></li><li><a class="nounderline abstract_t">Miodovnik A, Harstad E, Sideridis G, Huntington N. Timing of the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder. Pediatrics 2015; 136:e830.</a></li><li><a class="nounderline abstract_t">Clark B, Bélanger SA. ADHD in children and youth: Part 3-Assessment and treatment with comorbid ASD, ID, or prematurity. Paediatr Child Health 2018; 23:485.</a></li><li><a class="nounderline abstract_t">Matson JL, Cervantes PE. Commonly studied comorbid psychopathologies among persons with autism spectrum disorder. Res Dev Disabil 2014; 35:952.</a></li><li><a class="nounderline abstract_t">Rao PA, Landa RJ. Association between severity of behavioral phenotype and comorbid attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders. Autism 2014; 18:272.</a></li><li><a class="nounderline abstract_t">Antshel KM, Russo N. Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations. Curr Psychiatry Rep 2019; 21:34.</a></li><li><a class="nounderline abstract_t">Millichap JG. Etiologic classification of attention-deficit/hyperactivity disorder. Pediatrics 2008; 121:e358.</a></li><li><a class="nounderline abstract_t">Taylor E, Döpfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry 2004; 13 Suppl 1:I7.</a></li><li><a class="nounderline abstract_t">Levy F, Hay DA, McStephen M, et al. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997; 36:737.</a></li><li><a class="nounderline abstract_t">Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet 2016; 387:1240.</a></li><li><a class="nounderline abstract_t">Faraone SV, Biederman J, Monuteaux MC. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genet Epidemiol 2000; 18:1.</a></li><li><a class="nounderline abstract_t">Thapar A, Cooper M, Eyre O, Langley K. What have we learnt about the causes of ADHD? J Child Psychol Psychiatry 2013; 54:3.</a></li><li><a class="nounderline abstract_t">Williams NM, Zaharieva I, Martin A, et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010; 376:1401.</a></li><li><a class="nounderline abstract_t">Albajara Sáenz A, Villemonteix T, Massat I. Structural and functional neuroimaging in attention-deficit/hyperactivity disorder. Dev Med Child Neurol 2019; 61:399.</a></li><li><a class="nounderline abstract_t">Giedd JN, Blumenthal J, Molloy E, Castellanos FX. Brain imaging of attention deficit/hyperactivity disorder. Ann N Y Acad Sci 2001; 931:33.</a></li><li><a class="nounderline abstract_t">Castellanos FX, Lee PP, Sharp W, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002; 288:1740.</a></li><li><a class="nounderline abstract_t">Sowell ER, Thompson PM, Welcome SE, et al. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 2003; 362:1699.</a></li><li><a class="nounderline abstract_t">Jacobson LA, Crocetti D, Dirlikov B, et al. Anomalous Brain Development Is Evident in Preschoolers With Attention-Deficit/Hyperactivity Disorder. J Int Neuropsychol Soc 2018; 24:531.</a></li><li><a class="nounderline abstract_t">Seidman LJ, Valera EM, Makris N, et al. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry 2006; 60:1071.</a></li><li><a class="nounderline abstract_t">Makris N, Biederman J, Valera EM, et al. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex 2007; 17:1364.</a></li><li><a class="nounderline abstract_t">Shaw P, Lerch J, Greenstein D, et al. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2006; 63:540.</a></li><li><a class="nounderline abstract_t">Dickstein SG, Bannon K, Castellanos FX, Milham MP. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry 2006; 47:1051.</a></li><li><a class="nounderline abstract_t">Bush G, Frazier JA, Rauch SL, et al. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry 1999; 45:1542.</a></li><li><a class="nounderline abstract_t">Rubia K, Overmeyer S, Taylor E, et al. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am J Psychiatry 1999; 156:891.</a></li><li><a class="nounderline abstract_t">Rubia K, Smith AB, Brammer MJ, et al. Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. Am J Psychiatry 2005; 162:1067.</a></li><li><a class="nounderline abstract_t">Zang YF, Jin Z, Weng XC, et al. Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality. Brain Dev 2005; 27:544.</a></li><li><a class="nounderline abstract_t">Hart H, Radua J, Nakao T, et al. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 2013; 70:185.</a></li><li><a class="nounderline abstract_t">McCarthy H, Skokauskas N, Frodl T. Identifying a consistent pattern of neural function in attention deficit hyperactivity disorder: a meta-analysis. Psychol Med 2014; 44:869.</a></li><li><a class="nounderline abstract_t">Spencer TJ, Brown A, Seidman LJ, et al. Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies. J Clin Psychiatry 2013; 74:902.</a></li><li><a class="nounderline abstract_t">Vaidya CJ, Austin G, Kirkorian G, et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci U S A 1998; 95:14494.</a></li><li><a class="nounderline abstract_t">Bouziane C, Filatova OG, Schrantee A, et al. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder. Radiology 2019; 293:186.</a></li><li><a class="nounderline abstract_t">Pennington BF, Ozonoff S. Executive functions and developmental psychopathology. J Child Psychol Psychiatry 1996; 37:51.</a></li><li class="breakAll">Barkley RA. Theories of attention-deficit/hyperactivity disorder. In: Handbook of Disruptive Behavior Disorders, Quay HC, Hogan AE (Eds), Kluwer Academic/Plenum, New York 1999. p.295.</li><li><a class="nounderline abstract_t">Himelstein J, Newcorn JH, Halperin JM. The neurobiology of attention-deficit hyperactivity disorder. Front Biosci 2000; 5:D461.</a></li><li><a class="nounderline abstract_t">Tannock R. Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 1998; 39:65.</a></li><li><a class="nounderline abstract_t">Hauser TU, Iannaccone R, Ball J, et al. Role of the medial prefrontal cortex in impaired decision making in juvenile attention-deficit/hyperactivity disorder. JAMA Psychiatry 2014; 71:1165.</a></li><li><a class="nounderline abstract_t">Arnsten AF, Pliszka SR. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacol Biochem Behav 2011; 99:211.</a></li><li><a class="nounderline abstract_t">Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 1999; 46:1234.</a></li><li><a class="nounderline abstract_t">Russell V, Allie S, Wiggins T. Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat. Behav Brain Res 2000; 117:69.</a></li><li><a class="nounderline abstract_t">Dougherty DD, Bonab AA, Spencer TJ, et al. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999; 354:2132.</a></li><li><a class="nounderline abstract_t">Volkow ND, Wang G, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001; 21:RC121.</a></li><li><a class="nounderline abstract_t">Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 2007; 96:1269.</a></li><li><a class="nounderline abstract_t">Barrett JR. Diet &amp; nutrition: hyperactive ingredients? Environ Health Perspect 2007; 115:A578.</a></li><li><a class="nounderline abstract_t">Sampson HA, Aceves S, Bock SA, et al. Food allergy: a practice parameter update-2014. J Allergy Clin Immunol 2014; 134:1016.</a></li><li class="breakAll">National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: Diagnosis and management. NICE guideline [NG87], March 2018. https://www.nice.org.uk/guidance/NG87 (Accessed on October 09, 2019).</li><li><a class="nounderline abstract_t">Schab DW, Trinh NH. Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials. J Dev Behav Pediatr 2004; 25:423.</a></li><li><a class="nounderline abstract_t">Rojas NL, Chan E. Old and new controversies in the alternative treatment of attention-deficit hyperactivity disorder. Ment Retard Dev Disabil Res Rev 2005; 11:116.</a></li><li><a class="nounderline abstract_t">Stevens LJ, Kuczek T, Burgess JR, et al. Dietary sensitivities and ADHD symptoms: thirty-five years of research. Clin Pediatr (Phila) 2011; 50:279.</a></li><li><a class="nounderline abstract_t">Nigg JT, Lewis K, Edinger T, Falk M. Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry 2012; 51:86.</a></li><li><a class="nounderline abstract_t">Millichap JG, Yee MM. The diet factor in attention-deficit/hyperactivity disorder. Pediatrics 2012; 129:330.</a></li><li><a class="nounderline abstract_t">Sonuga-Barke EJ, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 2013; 170:275.</a></li><li class="breakAll">Quick Minutes: Food Advisory Committee Meeting March 30-31, 2011. www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/FoodAdvisoryCommittee/ucm250901.htm (Accessed on May 12, 2011).</li><li><a class="nounderline abstract_t">Feingold BF. Hyperkinesis and learning disabilities linked to artificial food flavors and colors. Am J Nurs 1975; 75:797.</a></li><li><a class="nounderline abstract_t">Bateman B, Warner JO, Hutchinson E, et al. The effects of a double blind, placebo controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children. Arch Dis Child 2004; 89:506.</a></li><li><a class="nounderline abstract_t">Krummel DA, Seligson FH, Guthrie HA. Hyperactivity: is candy causal? Crit Rev Food Sci Nutr 1996; 36:31.</a></li><li><a class="nounderline abstract_t">DiBattista D, Shepherd ML. Primary school teachers' beliefs and advice to parents concerning sugar consumption and activity in children. Psychol Rep 1993; 72:47.</a></li><li><a class="nounderline abstract_t">Weber W, Newmark S. Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism. Pediatr Clin North Am 2007; 54:983.</a></li><li><a class="nounderline abstract_t">Wolraich ML, Wilson DB, White JW. The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA 1995; 274:1617.</a></li><li><a class="nounderline abstract_t">Del-Ponte B, Quinte GC, Cruz S, et al. Dietary patterns and attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis. J Affect Disord 2019; 252:160.</a></li><li><a class="nounderline abstract_t">Egger J, Carter CM, Graham PJ, et al. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet 1985; 1:540.</a></li><li><a class="nounderline abstract_t">Egger J, Stolla A, McEwen LM. Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome. Lancet 1992; 339:1150.</a></li><li><a class="nounderline abstract_t">Carter CM, Urbanowicz M, Hemsley R, et al. Effects of a few food diet in attention deficit disorder. Arch Dis Child 1993; 69:564.</a></li><li><a class="nounderline abstract_t">Schmidt MH, Möcks P, Lay B, et al. Does oligoantigenic diet influence hyperactive/conduct-disordered children--a controlled trial. Eur Child Adolesc Psychiatry 1997; 6:88.</a></li><li><a class="nounderline abstract_t">Pelsser LM, Frankena K, Toorman J, et al. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial. Lancet 2011; 377:494.</a></li><li><a class="nounderline abstract_t">Ghuman JK. Restricted elimination diet for ADHD: the INCA study. Lancet 2011; 377:446.</a></li><li><a class="nounderline abstract_t">Bekaroğlu M, Aslan Y, Gedik Y, et al. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note. J Child Psychol Psychiatry 1996; 37:225.</a></li><li><a class="nounderline abstract_t">Sorgi PJ, Hallowell EM, Hutchins HL, Sears B. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr J 2007; 6:16.</a></li><li><a class="nounderline abstract_t">Stevens LJ, Zentall SS, Deck JL, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995; 62:761.</a></li><li><a class="nounderline abstract_t">Raz R, Gabis L. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev Med Child Neurol 2009; 51:580.</a></li><li><a class="nounderline abstract_t">Parletta N, Niyonsenga T, Duff J. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls. PLoS One 2016; 11:e0156432.</a></li><li><a class="nounderline abstract_t">Gillies D, Sinn JKh, Lad SS, et al. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev 2012; :CD007986.</a></li><li><a class="nounderline abstract_t">Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2011; 50:991.</a></li><li><a class="nounderline abstract_t">Chang JP, Su KP, Mondelli V, Pariante CM. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies. Neuropsychopharmacology 2018; 43:534.</a></li><li><a class="nounderline abstract_t">Bernstein AS, Oken E, de Ferranti S, et al. Fish, Shellfish, and Children's Health: An Assessment of Benefits, Risks, and Sustainability. Pediatrics 2019.</a></li><li><a class="nounderline abstract_t">Halterman JS, Kaczorowski JM, Aligne CA, et al. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 2001; 107:1381.</a></li><li><a class="nounderline abstract_t">Konofal E, Lecendreux M, Arnulf I, Mouren MC. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2004; 158:1113.</a></li><li><a class="nounderline abstract_t">Cortese S, Konofal E, Lecendreux M, et al. Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep 2005; 28:1007.</a></li><li><a class="nounderline abstract_t">Kwon S, Sohn Y, Jeong SH, et al. Prevalence of restless legs syndrome and sleep problems in Korean children and adolescents with attention deficit hyperactivity disorder: a single institution study. Korean J Pediatr 2014; 57:317.</a></li><li><a class="nounderline abstract_t">Konofal E, Lecendreux M, Deron J, et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 2008; 38:20.</a></li><li><a class="nounderline abstract_t">Millichap JG, Yee MM, Davidson SI. Serum ferritin in children with attention-deficit hyperactivity disorder. Pediatr Neurol 2006; 34:200.</a></li><li><a class="nounderline abstract_t">Hollowell JG, van Assendelft OW, Gunter EW, et al. Hematological and iron-related analytes--reference data for persons aged 1 year and over: United States, 1988-94. Vital Health Stat 11 2005; :1.</a></li><li><a class="nounderline abstract_t">Donfrancesco R, Parisi P, Vanacore N, et al. Iron and ADHD: time to move beyond serum ferritin levels. J Atten Disord 2013; 17:347.</a></li><li><a class="nounderline abstract_t">Arnold LE, DiSilvestro RA. Zinc in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2005; 15:619.</a></li><li><a class="nounderline abstract_t">Arnold LE, Bozzolo H, Hollway J, et al. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2005; 15:628.</a></li><li><a class="nounderline abstract_t">Ghanizadeh A, Berk M. Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder: a systematic review of randomized controlled clinical trials. Eur J Clin Nutr 2013; 67:122.</a></li><li><a class="nounderline abstract_t">Huang L, Wang Y, Zhang L, et al. Maternal Smoking and Attention-Deficit/Hyperactivity Disorder in Offspring: A Meta-analysis. Pediatrics 2018; 141.</a></li><li><a class="nounderline abstract_t">Sourander A, Sucksdorff M, Chudal R, et al. Prenatal Cotinine Levels and ADHD Among Offspring. Pediatrics 2019; 143.</a></li><li><a class="nounderline abstract_t">Gustavson K, Ystrom E, Stoltenberg C, et al. Smoking in Pregnancy and Child ADHD. Pediatrics 2017; 139.</a></li><li><a class="nounderline abstract_t">Schechter JC, Kollins SH. Prenatal Smoke Exposure and ADHD: Advancing the Field. Pediatrics 2017; 139.</a></li><li><a class="nounderline abstract_t">Thapar A, Rice F, Hay D, et al. Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry 2009; 66:722.</a></li><li><a class="nounderline abstract_t">Linnet KM, Dalsgaard S, Obel C, et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 2003; 160:1028.</a></li><li><a class="nounderline abstract_t">Mick E, Biederman J, Faraone SV, et al. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 2002; 41:378.</a></li><li><a class="nounderline abstract_t">Aronson M, Hagberg B, Gillberg C. Attention deficits and autistic spectrum problems in children exposed to alcohol during gestation: a follow-up study. Dev Med Child Neurol 1997; 39:583.</a></li><li><a class="nounderline abstract_t">Knopik VS, Heath AC, Jacob T, et al. Maternal alcohol use disorder and offspring ADHD: disentangling genetic and environmental effects using a children-of-twins design. Psychol Med 2006; 36:1461.</a></li><li><a class="nounderline abstract_t">Boyd TA, Ernhart CB, Greene TH, et al. Prenatal alcohol exposure and sustained attention in the preschool years. Neurotoxicol Teratol 1991; 13:49.</a></li><li><a class="nounderline abstract_t">Asarnow RF, Newman N, Weiss RE, Su E. Association of Attention-Deficit/Hyperactivity Disorder Diagnoses With Pediatric Traumatic Brain Injury: A Meta-analysis. JAMA Pediatr 2021; 175:1009.</a></li></ol></div><div id="topicVersionRevision">Topic 602 Version 44.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : American Psychiatric Association. Attention-deficit/hyperactivity disorder. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, American Psychiatric Association, Washington, DC 2022. p.68.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15176722" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20008426" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29363986" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31570648" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23677130" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Mental health surveillance among children--United States, 2005-2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24342384" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22956714" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The prevalence of ADHD: its diagnosis and treatment in four school districts across two states.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24336124" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The Prevalence of ADHD in a Population-Based Sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31558576" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25733754" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30646132" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30646132" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21300675" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11211363" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15782084" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Gender differences in ADHD subtype comorbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2018156" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25343695" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : "Complex" attention-deficit hyperactivity disorder, more norm than exception? Diagnoses and comorbidities in a developmental clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27694280" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Patterns of Comorbidity Among Girls With ADHD: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30681669" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : ADHD in children and youth: Part 1-Etiology, diagnosis, and comorbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31996577" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31996578" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder: Process of Care Algorithms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17581453" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8714320" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9648041" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10944655" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9729691" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Attention-deficit hyperactivity disorder subtypes and comorbid disruptive behaviour disorders in a child and adolescent mental health clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2033106" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The adolescent outcome of hyperactive children diagnosed by research criteria--III. Mother-child interactions, family conflicts and maternal psychopathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9680053" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15661592" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Attention deficit disorder and hospitalization owing to intra- and interpersonal violence among children and young adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3377645" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Risk factors for adolescent suicide. A comparison of adolescent suicide victims with suicidal inpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10408264" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Assessing varying degrees of lethality in depressed adolescent suicide attempters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20876182" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Gender, attention-deficit/hyperactivity disorder, and reading disability in a population-based birth cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21859915" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Written-language disorder among children with and without ADHD in a population-based birth cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Issues in the definition and classification of attention deficit disorder</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28914082" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Characterizing psychiatric comorbidity in children with autism spectrum disorder receiving publicly funded mental health services.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31530292" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Autistic spectrum disorder symptoms in children and adolescents with attention-deficit/hyperactivity disorder: a meta-analytical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26371198" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Timing of the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30681666" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : ADHD in children and youth: Part 3-Assessment and treatment with comorbid ASD, ID, or prematurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24629541" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Commonly studied comorbid psychopathologies among persons with autism spectrum disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23739542" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Association between severity of behavioral phenotype and comorbid attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30903299" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18245408" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Etiologic classification of attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15322953" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : European clinical guidelines for hyperkinetic disorder -- first upgrade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9183127" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26386541" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Attention deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10603455" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22963644" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : What have we learnt about the causes of ADHD?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20888040" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30276811" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Structural and functional neuroimaging in attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11462751" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Brain imaging of attention deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12365958" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14643117" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29576028" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Anomalous Brain Development Is Evident in Preschoolers With Attention-Deficit/Hyperactivity Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16876137" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16920883" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16651511" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17073984" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10376114" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10360128" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15930054" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15876503" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23247506" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23663382" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Identifying a consistent pattern of neural function in attention deficit hyperactivity disorder: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24107764" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9826728" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31407970" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8655658" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Executive functions and developmental psychopathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8655658" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Executive functions and developmental psychopathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10762596" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : The neurobiology of attention-deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9534087" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25142296" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Role of the medial prefrontal cortex in impaired decision making in juvenile attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21295057" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10560028" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11099759" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10609822" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Dopamine transporter density in patients with attention deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11160455" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17718779" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Environmental risk factors for attention-deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18087571" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Diet&amp;nutrition: hyperactive ingredients?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25174862" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Food allergy: a practice parameter update-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25174862" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Food allergy: a practice parameter update-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15613992" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15977318" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Old and new controversies in the alternative treatment of attention-deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21127082" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Dietary sensitivities and ADHD symptoms: thirty-five years of research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22176942" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22232312" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The diet factor in attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23360949" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23360949" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1039267" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Hyperkinesis and learning disabilities linked to artificial food flavors and colors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15155391" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : The effects of a double blind, placebo controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8747098" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Hyperactivity: is candy causal?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8451373" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Primary school teachers' beliefs and advice to parents concerning sugar consumption and activity in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18061787" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7474248" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : The effect of sugar on behavior or cognition in children. A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30986731" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Dietary patterns and attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2857900" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1349376" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8257176" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Effects of a few food diet in attention deficit disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9257090" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Does oligoantigenic diet influence hyperactive/conduct-disordered children--a controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21296237" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21296224" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Restricted elimination diet for ADHD: the INCA study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8682903" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17629918" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7572706" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19549202" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27232999" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22786509" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21961774" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28741625" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31110165" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Fish, Shellfish, and Children's Health: An Assessment of Benefits, Risks, and Sustainability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11389261" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15583094" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Iron deficiency in children with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16218085" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25114692" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Prevalence of restless legs syndrome and sleep problems in Korean children and adolescents with attention deficit hyperactivity disorder: a single institution study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18054688" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Effects of iron supplementation on attention deficit hyperactivity disorder in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16504789" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Serum ferritin in children with attention-deficit hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15782774" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Hematological and iron-related analytes--reference data for persons aged 1 year and over: United States, 1988-94.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22290693" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Iron and ADHD: time to move beyond serum ferritin levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16190793" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Zinc in attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16190794" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23169472" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder: a systematic review of randomized controlled clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29288161" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Maternal Smoking and Attention-Deficit/Hyperactivity Disorder in Offspring: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30804074" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Prenatal Cotinine Levels and ADHD Among Offspring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28138005" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Smoking in Pregnancy and Child ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28138004" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Prenatal Smoke Exposure and ADHD: Advancing the Field.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19596120" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12777257" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11931593" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9344050" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Attention deficits and autistic spectrum problems in children exposed to alcohol during gestation: a follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16734942" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Maternal alcohol use disorder and offspring ADHD: disentangling genetic and environmental effects using a children-of-twins design.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2046626" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Prenatal alcohol exposure and sustained attention in the preschool years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34251435" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Association of Attention-Deficit/Hyperactivity Disorder Diagnoses With Pediatric Traumatic Brain Injury: A Meta-analysis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
